Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer

BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-PTX) has shown non-inferiority to paclitaxel (PTX) as second-line therapy for advanced gastric cancer (AGC) with fewer infusion-related reactions. The efficacy and safety of nab-PTX plus ramucirumab (RAM) was reported in a phase II trial; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Okunaka, Mashiro, Kotani, Daisuke, Demachi, Ken, Kawazoe, Akihito, Yoshino, Takayuki, Kawasaki, Toshikatsu, Shitara, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670803/
https://www.ncbi.nlm.nih.gov/pubmed/33198652
http://dx.doi.org/10.1186/s12885-020-07614-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670803/
https://www.ncbi.nlm.nih.gov/pubmed/33198652
http://dx.doi.org/10.1186/s12885-020-07614-6

Ejemplares similares